These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 22251934

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A, Samuraki M, Furui E, Iwasa K, Yoshikawa H, Hayashi S, Yamada M.
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [Abstract] [Full Text] [Related]

  • 25. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ, Huijbers MG, van der Maarel SM, Verschuuren JJ.
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [Abstract] [Full Text] [Related]

  • 26. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW, Morsch M, Phillips WD.
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Muscle-specific kinase antibodies: a novel cause of peripheral nerve hyperexcitability?
    Simon NG, Reddel SW, Kiernan MC, Layzer R.
    Muscle Nerve; 2013 Nov; 48(5):819-23. PubMed ID: 23720161
    [Abstract] [Full Text] [Related]

  • 29. [Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis].
    Konishi T, Kousaka M, Yamakawa K, Matsui M, Ohta K.
    Rinsho Shinkeigaku; 2009 Oct; 49(10):660-3. PubMed ID: 19999149
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
    Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.
    Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
    [Abstract] [Full Text] [Related]

  • 34. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB, Hunt CH, Batish SD.
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [Abstract] [Full Text] [Related]

  • 35. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 36. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
    Modoni A, Mastrorosa A, Spagni G, Evoli A.
    Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
    [Abstract] [Full Text] [Related]

  • 37. Seronegative myasthenia gravis.
    Vincent A, McConville J, Farrugia ME, Newsom-Davis J.
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S, Salort-Campana E, Franques J, Uzenot D, Pouget J.
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.